In the last 12 months, insiders at Nuvation Bio Inc. ($NUVB) filed 144 transactions with the SEC: 24 open-market purchases totaling $18,513,463 and 12 sales totaling $6,426,535. Net insider sentiment: net buying.
Nuvation Bio Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- NODELMAN OLEG (Director) — 6 transactions totaling $13,384,530
- Hattersley Gary (CHIEF SCIENTIFIC OFFICER) — 12 transactions totaling $4,045,740
- Cui Xiangmin (Not found) — 20 transactions totaling $2,317,734
- Liu Dongfang (CHIEF MEDICAL OFFICER) — 24 transactions totaling $2,310,382
- Hanley David C. (CHIEF TECHNICAL OPERATIONS) — 6 transactions totaling $1,801,680
View all SEC Filings for Nuvation Bio Inc. (NUVB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| Feb. 27, 2026 | Cui Xiangmin | Not found | A | Stock Option (Right to Buy) | 74813 | $0.00 | 74,813.0000 | 342,833,433 | 9999.99% | 0.02% |
| Feb. 27, 2026 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| Feb. 27, 2026 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| Feb. 27, 2026 | Hung David | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 1995012 | $0.00 | 1,995,012.0000 | 342,833,433 | 9999.99% | 0.58% |
| Feb. 27, 2026 | Liu Dongfang | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| Feb. 27, 2026 | Makunje Moses | SEE REMARKS | A | Class A Common Stock | 50761 | $0.00 | 68,137.0000 | 342,833,433 | 292.13% | 0.01% |
| Feb. 27, 2026 | Makunje Moses | SEE REMARKS | A | Stock Option (Right to Buy) | 224439 | $0.00 | 224,439.0000 | 342,833,433 | 9999.99% | 0.07% |
| Feb. 27, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| Feb. 27, 2026 | Sjogren Colleen | Chief Commercial Officer | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| Feb. 27, 2026 | Sauvage Philippe | Chief Financial Officer | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| Dec. 1, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 150000 | $0.00 | 165,000.0000 | 342,833,433 | 47.62% | 0.04% |
| Dec. 1, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 150000 | $2.93 | 168,000.0000 | 342,833,433 | 833.33% | 0.04% |
| Dec. 1, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 150000 | $7.82 | 18,000.0000 | 342,833,433 | 89.29% | 0.04% |
| Nov. 25, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 480,000.0000 | 342,833,433 | 2.04% | 0.00% |
| Nov. 26, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 10000 | $3.61 | 28,000.0000 | 342,833,433 | 55.56% | 0.00% |
| Nov. 25, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 10000 | $7.50 | 18,000.0000 | 342,833,433 | 35.71% | 0.00% |
| Nov. 25, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 10000 | $3.61 | 28,000.0000 | 342,833,433 | 55.56% | 0.00% |
| Nov. 26, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 10000 | $8.00 | 18,000.0000 | 342,833,433 | 35.71% | 0.00% |
| Nov. 26, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 470,000.0000 | 342,833,433 | 2.08% | 0.00% |
| Nov. 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M | Class A Common Stock | 69051 | $1.74 | 69,051.0000 | 342,833,433 | 9999.99% | 0.02% |
| Nov. 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 300000 | $0.00 | 200,000.0000 | 342,833,433 | 60.00% | 0.09% |
| Nov. 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 69051 | $0.00 | 229,884.0000 | 342,833,433 | 23.10% | 0.02% |
| Nov. 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | S | Class A Common Stock | 300000 | $7.23 | 0.0000 | 342,833,433 | 100.00% | 0.09% |
| Nov. 20, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 20000 | $1.87 | 38,000.0000 | 342,833,433 | 111.11% | 0.01% |
| Nov. 20, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 20000 | $7.00 | 18,000.0000 | 342,833,433 | 52.63% | 0.01% |
| Nov. 20, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 20000 | $0.00 | 450,000.0000 | 342,833,433 | 4.26% | 0.01% |
| Nov. 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M | Class A Common Stock | 300000 | $1.94 | 300,000.0000 | 342,833,433 | 9999.99% | 0.09% |
| Nov. 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | S | Class A Common Stock | 69051 | $7.23 | 0.0000 | 342,833,433 | 100.00% | 0.02% |
| Nov. 19, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | M | Class A Common Stock | 200000 | $1.87 | 224,000.0000 | 342,833,433 | 833.33% | 0.06% |
| Nov. 19, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | S | Class A Common Stock | 200000 | $7.14 | 24,000.0000 | 342,833,433 | 89.29% | 0.06% |
| Nov. 19, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | M | Stock Option (Right to Buy) | 200000 | $0.00 | 300,000.0000 | 342,833,433 | 40.00% | 0.06% |
| Nov. 19, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 15000 | $1.87 | 30,000.0000 | 342,833,433 | 100.00% | 0.00% |
| Nov. 19, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 15000 | $5.10 | 18,000.0000 | 342,833,433 | 45.45% | 0.00% |
| Nov. 17, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 15000 | $0.00 | 485,000.0000 | 342,833,433 | 3.00% | 0.00% |
| Nov. 19, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 15000 | $0.00 | 470,000.0000 | 342,833,433 | 3.09% | 0.00% |
| Nov. 17, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 15000 | $1.87 | 30,000.0000 | 342,833,433 | 100.00% | 0.00% |
| Nov. 17, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 15000 | $4.77 | 15,000.0000 | 342,833,433 | 50.00% | 0.00% |
| Oct. 27, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | S | Class A Common Stock | 100000 | $5.02 | 0.0000 | 342,833,433 | 100.00% | 0.03% |
| Oct. 27, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M | Class A Common Stock | 100000 | $1.74 | 100,000.0000 | 342,833,433 | 9999.99% | 0.03% |
| Oct. 27, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 100000 | $0.00 | 298,935.0000 | 342,833,433 | 25.07% | 0.03% |
| Aug. 11, 2025 | Mashal Robert | Not found | G | Stock Option (Right to Buy) | 350001 | $0.00 | 391,178.0000 | 337,678,855 | 47.22% | 0.10% |
| Aug. 11, 2025 | Mashal Robert | Not found | G | Stock Option (Right to buy) | 350001 | $0.00 | 350,001.0000 | 337,678,855 | 9999.99% | 0.10% |
| June 16, 2025 | Sauvage Philippe | Chief Financial Officer | P | Class A Common Stock | 3300 | $1.84 | 5,902.0000 | 337,678,855 | 126.83% | 0.00% |
| June 16, 2025 | Sjogren Colleen | Chief Commercial Officer | P | Class A Common Stock | 50000 | $1.81 | 81,000.0000 | 337,678,855 | 161.29% | 0.01% |
| June 17, 2025 | Sauvage Philippe | Chief Financial Officer | P | Class A Common Stock | 4000 | $1.79 | 9,902.0000 | 337,678,855 | 67.77% | 0.00% |
| June 16, 2025 | Wentworth Kerry | CHIEF REGULATORY OFFICER | P | Class A Common Stock | 26000 | $1.79 | 26,000.0000 | 337,678,855 | 9999.99% | 0.01% |
| June 16, 2025 | Wentworth Kerry | CHIEF REGULATORY OFFICER | P | Class A Common Stock | 24000 | $1.80 | 50,000.0000 | 337,678,855 | 92.31% | 0.01% |
| June 16, 2025 | Hung David | PRESIDENT AND CEO | P | Class A Common Stock | 500000 | $1.79 | 59,281,054.0000 | 337,678,855 | 0.85% | 0.15% |
| June 18, 2025 | Markel Stacy | CHIEF PEOPLE OFFICER | P | Class A Common Stock | 10000 | $1.71 | 29,591.0000 | 337,678,855 | 51.04% | 0.00% |
| May 21, 2025 | FALBERG KATHRYN E | Not found | A | Stock Option (Right to Buy) | 292983 | $0.00 | 292,983.0000 | 337,678,855 | 9999.99% | 0.09% |
| May 21, 2025 | VERNON W ANTHONY | Not found | A | Stock Option (Right to Buy) | 292983 | $0.00 | 292,983.0000 | 337,678,855 | 9999.99% | 0.09% |
| May 21, 2025 | BLICKENSTAFF KIM D | Not found | A | Stock Option (Right to Buy) | 292983 | $0.00 | 292,983.0000 | 337,678,855 | 9999.99% | 0.09% |
| May 21, 2025 | Mashal Robert | Not found | A | Stock Option (Right to Buy) | 292983 | $0.00 | 292,983.0000 | 337,678,855 | 9999.99% | 0.09% |
| May 21, 2025 | Bazemore Robert B | Not found | A | Stock Option (Right to Buy) | 292983 | $0.00 | 292,983.0000 | 337,678,855 | 9999.99% | 0.09% |
| May 2, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 20000 | $1.94 | 480,000.0000 | 337,678,855 | 4.00% | 0.01% |
| May 2, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 20000 | $2.50 | 12,000.0000 | 337,678,855 | 62.50% | 0.01% |
| May 2, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 20000 | $1.94 | 32,000.0000 | 337,678,855 | 166.67% | 0.01% |
| April 4, 2025 | Hung David | PRESIDENT AND CEO | P | Class A Common Stock | 200000 | $1.66 | 58,481,054.0000 | 337,678,855 | 0.34% | 0.06% |
| April 7, 2025 | Hung David | PRESIDENT AND CEO | P | Class A Common Stock | 300000 | $1.63 | 58,781,054.0000 | 337,678,855 | 0.51% | 0.09% |
| April 1, 2025 | Mashal Robert | Not found | P | Class A Common Stock | 1100 | $1.67 | 101,100.0000 | 337,678,855 | 1.10% | 0.00% |
| April 1, 2025 | Mashal Robert | Not found | P | Class A Common Stock | 98900 | $1.67 | 200,000.0000 | 337,678,855 | 97.82% | 0.03% |
| Feb. 28, 2025 | Makunje Moses | SEE REMARKS | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2025 | Markel Stacy | CHIEF PEOPLE OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2025 | Wentworth Kerry | CHIEF REGULATORY OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2025 | Sjogren Colleen | Chief Commercial Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2025 | Sauvage Philippe | Chief Financial Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2025 | Hung David | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 2000000 | $0.00 | 2,000,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 11, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | S | Class A Common Stock | 56361 | $2.89 | 6,112,686.0000 | 0 | 0.91% | 0.00% |
| Oct. 8, 2024 | Mashal Robert | Not found | P | Class A Common Stock | 19 | $2.20 | 19.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Mashal Robert | Not found | P | Class A Common Stock | 99981 | $2.20 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 7, 2024 | Sauvage Philippe | Chief Financial Officer | A | Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Cui Xiangmin | Not found | A | Warrants (Right to Buy) | 437834 | $0.00 | 646,057.0000 | 0 | 210.27% | 0.00% |
| Sept. 3, 2024 | VERNON W ANTHONY | Not found | A | Stock Option (Right to Buy) | 200801 | $0.00 | 200,801.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | FALBERG KATHRYN E | Not found | A | Stock Option (Right to Buy) | 200801 | $0.00 | 200,801.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | BLICKENSTAFF KIM D | Not found | A | Stock Option (Right to Buy) | 200801 | $0.00 | 200,801.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Bazemore Robert B | Not found | A | Stock Option (Right to Buy) | 200801 | $0.00 | 200,801.0000 | 0 | 9999.99% | 0.00% |
| Sept. 4, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C | Class A Common Stock | 2543600 | $0.00 | 6,169,047.0000 | 0 | 70.16% | 0.00% |
| Sept. 4, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C | Class A Common Stock | 1695700 | $0.00 | 6,169,047.0000 | 0 | 37.91% | 0.00% |
| Sept. 3, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Series A Preferred Stock | 25436 | $0.00 | 25,436.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Series A Preferred Stock | 16957 | $0.00 | 16,957.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Warrants (Right to Buy) | 86471 | $0.00 | 144,118.0000 | 0 | 150.00% | 0.00% |
| Sept. 3, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Warrants (Right to Buy) | 57647 | $0.00 | 144,118.0000 | 0 | 66.67% | 0.00% |
| Sept. 4, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C | Series A Preferred Stock | 25436 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 4, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | C | Series A Preferred Stock | 16957 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 4, 2024 | Cui Xiangmin | Not found | C | Class A Common Stock | 967100 | $0.00 | 25,954,439.0000 | 0 | 3.87% | 0.00% |
| Sept. 4, 2024 | Cui Xiangmin | Not found | C | Class A Common Stock | 5157900 | $0.00 | 25,954,439.0000 | 0 | 24.80% | 0.00% |
| Sept. 4, 2024 | Cui Xiangmin | Not found | C | Class A Common Stock | 12879200 | $0.00 | 25,954,439.0000 | 0 | 98.50% | 0.00% |
| Sept. 3, 2024 | Cui Xiangmin | Not found | A | Series A Preferred Stock | 9671 | $0.00 | 9,671.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Cui Xiangmin | Not found | A | Series A Preferred Stock | 51579 | $0.00 | 51,579.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Cui Xiangmin | Not found | A | Series A Preferred Stock | 128792 | $0.00 | 128,792.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Cui Xiangmin | Not found | A | Warrants (Right to Buy) | 32877 | $0.00 | 646,057.0000 | 0 | 5.36% | 0.00% |
| Sept. 3, 2024 | Cui Xiangmin | Not found | A | Warrants (Right to Buy) | 175346 | $0.00 | 646,057.0000 | 0 | 37.25% | 0.00% |
| Sept. 4, 2024 | Cui Xiangmin | Not found | C | Series A Preferred Stock | 9671 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 4, 2024 | Cui Xiangmin | Not found | C | Series A Preferred Stock | 51579 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 4, 2024 | Cui Xiangmin | Not found | C | Series A Preferred Stock | 128792 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 25, 2024 | Cui Xiangmin | Not found | P | Class A Common Stock | 277895 | $2.97 | 6,950,239.0000 | 0 | 4.16% | 0.00% |
| June 20, 2024 | Cui Xiangmin | Not found | P | Class A Common Stock | 87715 | $2.99 | 6,260,059.0000 | 0 | 1.42% | 0.00% |
| June 24, 2024 | Cui Xiangmin | Not found | P | Class A Common Stock | 336874 | $2.98 | 6,672,344.0000 | 0 | 5.32% | 0.00% |
| June 21, 2024 | Cui Xiangmin | Not found | P | Class A Common Stock | 75411 | $3.00 | 6,335,470.0000 | 0 | 1.20% | 0.00% |
| June 11, 2024 | BLICKENSTAFF KIM D | Not found | P | Class A Common Stock | 172189 | $2.90 | 172,189.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | WELCH DANIEL G | Not found | M | Stock Option (Right to Buy) | 293203 | $0.00 | 19,547.0000 | 0 | 93.75% | 0.00% |
| May 24, 2024 | WELCH DANIEL G | Not found | M | Stock Option (Right to Buy) | 366744 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 24, 2024 | WELCH DANIEL G | Not found | M | Class A Common Stock | 293203 | $1.74 | 293,203.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | WELCH DANIEL G | Not found | M | Class A Common Stock | 366744 | $1.64 | 659,947.0000 | 0 | 125.08% | 0.00% |
| April 9, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Stock Option (Right to Buy) | 486669 | $0.00 | 486,669.0000 | 0 | 9999.99% | 0.00% |
| April 9, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Class A Common Stock | 550758 | $0.00 | 1,929,747.0000 | 0 | 39.94% | 0.00% |
| April 9, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Class A Common Stock | 1378989 | $0.00 | 1,929,747.0000 | 0 | 250.38% | 0.00% |
| April 9, 2024 | Sjogren Colleen | Chief Commercial Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| April 9, 2024 | Cui Xiangmin | Not found | A | Class A Common Stock | 4183002 | $0.00 | 6,172,344.0000 | 0 | 210.27% | 0.00% |
| April 9, 2024 | Cui Xiangmin | Not found | A | Class A Common Stock | 1675236 | $0.00 | 6,172,344.0000 | 0 | 37.25% | 0.00% |
| April 9, 2024 | Cui Xiangmin | Not found | A | Class A Common Stock | 314106 | $0.00 | 6,172,344.0000 | 0 | 5.36% | 0.00% |
| April 9, 2024 | Sjogren Colleen | Chief Commercial Officer | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| April 9, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | A | Stock Option (Right to Buy) | 388299 | $0.00 | 388,299.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Makunje Moses | SEE REMARKS | A | Class A Common Stock | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Hung David | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 2000000 | $0.00 | 2,000,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Liu Dongfang | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Markel Stacy | CHIEF PEOPLE OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Wentworth Kerry | CHIEF REGULATORY OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2024 | Mashal Robert | Not found | A | Stock Option (Right to Buy) | 741179 | $0.00 | 741,179.0000 | 0 | 9999.99% | 0.00% |
| Sept. 20, 2023 | NODELMAN OLEG | Director | P | Class A Common Stock | 117100 | $1.36 | 12,621,775.0000 | 0 | 0.94% | 0.00% |
| Sept. 21, 2023 | NODELMAN OLEG | Director | P | Class A Common Stock | 53000 | $1.36 | 12,674,775.0000 | 0 | 0.42% | 0.00% |
| Sept. 19, 2023 | NODELMAN OLEG | Director | P | Class A Common Stock | 5143000 | $1.26 | 12,504,675.0000 | 0 | 69.86% | 0.00% |
| Feb. 21, 2023 | NODELMAN OLEG | Director | P | Class A Common Stock | 53000 | $1.36 | 19,209,643.0000 | 0 | 0.28% | 0.00% |
| Feb. 19, 2023 | NODELMAN OLEG | Director | P | Class A Common Stock | 5143000 | $1.26 | 19,039,543.0000 | 0 | 37.01% | 0.00% |
| Feb. 20, 2023 | NODELMAN OLEG | Director | P | Class A Common Stock | 117100 | $1.36 | 19,156,643.0000 | 0 | 0.62% | 0.00% |
| May 15, 2023 | WELCH DANIEL G | Director | A | Stock Option (Right to Buy) | 366744 | $0.00 | 366,744.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2023 | Bazemore Robert B | Director | A | Stock Option (Right to Buy) | 366744 | $0.00 | 366,744.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2023 | BLICKENSTAFF KIM D | Director | A | Stock Option (Right to Buy) | 366744 | $0.00 | 366,744.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2023 | FALBERG KATHRYN E | Director | A | Stock Option (Right to Buy) | 366744 | $0.00 | 366,744.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2023 | VERNON W ANTHONY | Director | A | Stock Option (Right to Buy) | 366744 | $0.00 | 366,744.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Hattersley Gary | Chief Scientific Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Wentworth Kerry | Chief Regulatory Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Hanley David C. | Chief Technical Operations | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Fox Jennifer A. | Chief Financial Officer | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Hung David | President and CEO | A | Stock Option (Right to Buy) | 2500000 | $0.00 | 2,500,000.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2021 | Hung David | President and CEO | J | Class A Common Stock | 368408 | $0.00 | 58,281,054.0000 | 0 | 0.63% | 0.00% |
| Feb. 28, 2023 | Markel Stacy | Chief People Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Liu Dongfang | Chief Medical Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |